| 产品详情 |
| Edit |   |
|---|
| Product Name | Ozagrel |
|---|
| Description | Purity >98%. Inhibition of thromboxane synthase (TXAS), especially in human platelets, has been a clinical objective for many years. 1-Alkyl (N-alkyl)-imidazole derivatives have been recognized as TXAS inhibitors since the early 1980s. Ozagrel is a 1-alkyl imidazole derivative that acts as a selective inhibitor of TXAS with an IC50 of 11 nM. The beneficial effects of TXAS inhibition by ozagrel include improved motor coordination after experimental stroke, and antihypertensive effects in spontaneously hypertensive rats. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-2E-propenoic acid, OKY-046 |
|---|
| Gene, Accession, CAS # | CAS: 82571-53-7 |
|---|
| Catalog # | LS-H9230 |
|---|
| Price | |
|---|
| Order / More Info | Ozagrel from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|